NOT KNOWN DETAILS ABOUT PEMBROLIZUMAB RASH

Keytruda is often a brand (trade) name for pembrolizumab. It is actually given by intravenous infusion every a few to six weeks. Rarely, the use of Keytruda results in the immune system attacking wholesome tissues and this can cause severe side effects such as pneumonitis, colitis, or hepatitis. In a lot of people, the usage of Keytruda has resulte